ARTESUNATE COMBINED WITH PRAZIQUANTEL THERAPY MODULATE THE ANTIBODY RESPONSE IN MURINE SCHISTOSOMIASIS MANSONI | ||||
| Journal of the Egyptian Society of Parasitology | ||||
| Article 3, Volume 51, Issue 3, December 2021, Page 443-450 PDF (1.47 MB) | ||||
| Document Type: Original Article | ||||
| DOI: 10.21608/jesp.2021.210419 | ||||
 View on SCiNiTO | ||||
| Authors | ||||
| NEVEEN A. MADBOULY; AZZA M. EL AMIR | ||||
| Department of Zoology, Faculty of Science, Cairo University, Giza, Egypt | ||||
| Abstract | ||||
| This study evaluated the efficacy of praziquantel (PZQ), artesunate (AS) alone and combined PZQ-AS targeting Schistosoma mansoni immature-21days old schistosomula. PZQ & AS were administrated in a single oral dose (500 & 400mg/kg, respectively) alone or in combination 21 days post-infection (PI). Infected mice were sacrificed 56 days PI, parasitological, histological parameters and serum anti-SEA antibodies were evaluated. PZQ-monotherapy didn’t significantly affect total worm burden (TWB), female worm fecundity (FWF) or tissue egg load. AS-monotherapy significantly reduced TWB by 69.93%, FWF by 61.56% & tissue ova (hepatic by 91.54%& intestinal by 91.04%).Also, PZQ-AS combined treatment (21 days PI) significantly enhanced the developed worm eradication by 89.69%, FWF by 93.98% with maximal reduction of hepatic and intestinal egg load by 97.08 & 96.96%, respectively. Livers showed diminished granulomata when PZQ-AS was given 3 weeks PI with maximal drop in serum levels of anti-SEA specific IgM, total IgG, IgG1 & IgG2 antibodies. | ||||
| Keywords | ||||
| Schistosoma mansoni; Chemotherapy; Artesunate; Praziquantel; Immunoglobulins | ||||
|
Statistics Article View: 130 PDF Download: 156 |
||||
